Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 39

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 39
---
 do not anticipate                                              
 paying any cash dividends in the foreseeable future.                                                                                               |
| Transfer Agent                                   |     | Equity Stock Transfer, LLC.                                                                                                                        |
| Risk Factors                                     |     | You should carefully consider the information set forth in this prospectus and, in particular, the                                                 
 specific factors set forth in the “Risk Factors” section beginning on page 23 of this prospectus before deciding                                   
 whether or not to invest in shares of our common stock.                                                                                            |

| (1) | The number of shares of common stock to be outstanding after this offering                  
 is based on 1,472,891 shares of Common Stock outstanding as of March 27, 2025 and excludes: |

| ● | 57,068                                                                   
 shares of common stock reserved for future issuance under the 2022 Plan; |

| ● | 1,379,870                                                                                   
 shares of common stock issuable upon exercise of outstanding warrants at a weighted average 
 exercise price of $22.50 per share;                                                         |

| ● | 137,637 shares of common stock issuable upon exercise of outstanding options 
 at a weighted average exercise price of $13.92 per share;                    |

| ● | shares of common                                                                 
 stock issuable upon the conversion of 76,480 shares of Series A Preferred Stock. |

| (2) | Unless                                                                                          
 otherwise indicated, this prospectus supplement reflects and assumes no exercise of the options 
 and warrants described above.                                                                   |

22 RISK FACTORS Our business is subject to many risks and uncertainties, which may affect our future financial performance. If any of the events or circumstances described below occur, our business and financial performance could be adversely affected, our actual results could differ materially from our expectations, and the price of our stock could decline. The risks and uncertainties discussed below are not the only ones we face. There may be additional risks and uncertainties not currently known to us or that we currently do not believe are material that may adversely affect our business and financial performance. You should carefully consider the risks described below, together with all other information included in this prospectus, including our financial statements and related notes, before making an investment decision. The statements contained in this prospectus that are not historic facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. If any of the following risks actually occurs, our business, financial condition or results of operations could be harmed. In that case,